Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive perspective. Proponents often emphasize the potential for meaningful therapeutic outcomes, principally in conditions where conventional therapies have proven ineffective. However, crucially important to consider the considerable financial burden associated wit